Cosmo Pharma’s Male Hair Loss Treatment Shows Sustained Hair Growth in Year‑long Study
By Sneha S K and Sahil Pandey April 15 (Reuters) – Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth and long-term safety in men with common pattern baldness after a year of use. The year‑long extension study follows late-stage data reported in December, when the topical drug, called clascoterone, …